Michael J Peluso Selected Research

Creatine

12/2015

Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael J Peluso Research Topics

Disease

36	COVID-19 04/2024 - 01/2021
27	Infections 01/2024 - 06/2013
14	Post-Acute COVID-19 Syndrome 01/2024 - 01/2022
6	Inflammation (Inflammations) 10/2023 - 01/2020
5	HIV Infections (HIV Infection) 11/2021 - 06/2013
3	Viremia 11/2023 - 07/2022
3	Neurologic Manifestations (Neurological Manifestations) 01/2021 - 09/2012
2	Virus Diseases (Viral Diseases) 10/2023 - 01/2023
2	Reinfection 09/2023 - 01/2022
2	Asymptomatic Infections 08/2023 - 10/2022
2	Fatigue 01/2023 - 07/2022
2	Fever (Fevers) 07/2021 - 03/2021
2	Cough 07/2021 - 03/2021
2	Neuroinflammatory Diseases 01/2021 - 06/2013
2	Neoplasms (Cancer) 04/2020 - 06/2019
1	Thrombocytopenia (Thrombopenia) 10/2023
1	Dysbiosis 01/2023
1	Multibacillary Leprosy 01/2022
1	Leprosy (Hansen's Disease) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	Chest Pain (Chest Pains) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Tuberculoid Leprosy 01/2022
1	Pericardial Effusion 01/2022
1	Hidradenitis Suppurativa 11/2021
1	Joint Diseases (Joint Disease) 11/2021
1	Arthritis (Polyarthritis) 11/2021
1	Kaposi Sarcoma (Kaposi's Sarcoma) 11/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 08/2021
1	Lung Diseases (Lung Disease) 03/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2020
1	Opportunistic Infections (Opportunistic Infection) 04/2020
1	Coccidioidomycosis 04/2020
1	Coinfection 04/2020

Drug/Important Bio-Agent (IBA)

10	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2020
8	Proteins (Proteins, Gene)FDA Link 10/2023 - 09/2012
8	Biomarkers (Surrogate Marker)IBA 05/2023 - 06/2013
7	AntigensIBA 04/2024 - 07/2022
7	Antiviral Agents (Antivirals)IBA 11/2023 - 05/2020
4	COVID-19 VaccinesIBA 11/2023 - 08/2021
4	AntibodiesIBA 11/2023 - 01/2022
4	Clostridium perfringens epsilon-toxinIBA 03/2023 - 06/2022
4	Immunoglobulin G (IgG)IBA 01/2023 - 01/2021
3	AutoantibodiesIBA 11/2023 - 01/2023
3	InterferonsIBA 11/2023 - 10/2021
3	CytokinesIBA 10/2022 - 06/2019
2	nirmatrelvir and ritonavir drug combinationIBA 01/2024 - 09/2023
2	nirmatrelvirIBA 01/2024 - 01/2022
2	Neutralizing AntibodiesIBA 11/2023 - 03/2023
2	Broadly Neutralizing AntibodiesIBA 11/2023 - 03/2023
2	Tryptophan (L-Tryptophan)FDA Link 10/2023 - 01/2022
2	HLA-B Antigens (HLA-B)IBA 08/2023 - 10/2022
2	HLA Antigens (Human Leukocyte Antigens)IBA 08/2023 - 10/2022
2	Viral RNAIBA 07/2023 - 09/2022
2	ProteomeIBA 02/2023 - 01/2023
2	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 02/2023 - 01/2023
2	AutoantigensIBA 02/2023 - 01/2023
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2023 - 07/2022
2	Nucleic AcidsIBA 10/2022 - 03/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2021
2	VaccinesIBA 01/2022 - 01/2022
2	Oxygen (Dioxygen)IBA 07/2021 - 03/2021
2	Amyloid beta-PeptidesIBA 01/2021 - 06/2013
2	Protons (Proton)IBA 12/2015 - 06/2013
1	Interferon Type IIBA 10/2023
1	Viral AntigensIBA 10/2023
1	Serotonin (5 Hydroxytryptamine)IBA 10/2023
1	Monoamine Oxidase (MAO)IBA 10/2023
1	RadiopharmaceuticalsIBA 07/2023
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2023
1	ensitrelvirIBA 05/2023
1	Antinuclear AntibodiesIBA 10/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 09/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Minocycline (Cyclops)FDA LinkGeneric 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022
1	GlucansIBA 01/2022
1	Moxifloxacin (Avelox)FDA Link 01/2022
1	Biological FactorsIBA 12/2021
1	Peptides (Polypeptides)IBA 10/2021
1	Messenger RNA (mRNA)IBA 08/2021
1	NeurograninIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	cyclo(Arg-Pro) (CI 4)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2020
1	Immunomodulating AgentsIBA 04/2020
1	idelalisibIBA 04/2020
1	Indicators and Reagents (Reagents)IBA 02/2020

Therapy/Procedure

9	Therapeutics 01/2022 - 09/2012
3	Art Therapy 11/2021 - 01/2020
2	Aftercare (After-Treatment) 01/2024 - 12/2015
1	Biological Therapy 11/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2021
1	Critical Care (Surgical Intensive Care) 03/2021
1	Immunomodulation 04/2020